AIM
STJ

Advantage Investment Management’s St Jude Medical STJ Stock Holding History

Advantage Investment Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-100
Closed -$6K – 1121
2017
Q3 		$6K Hold
100
– – ﹤0.01% 803
2017
Q2 		$6K Hold
100
– – ﹤0.01% 820
2017
Q1 		$6K Hold
100
– – ﹤0.01% 796
2016
Q4 		$6K Hold
100
– – ﹤0.01% 736
2016
Q3 		$6K Hold
100
– – ﹤0.01% 719
2016
Q2 		$6K Hold
100
– – ﹤0.01% 685
2016
Q1 		$6K Hold
100
– – ﹤0.01% 668
2015
Q4 		$6K Hold
100
– – ﹤0.01% 675
2015
Q3 		$6K Hold
100
– – ﹤0.01% 644
2015
Q2 		$6K Hold
100
– – ﹤0.01% 683
2015
Q1 		$6K Hold
100
– – ﹤0.01% 678
2014
Q4 		$6K Buy
+100
New +$6.44K ﹤0.01% 607

Advantage Investment Management's STJ Position: Q4 2017 in Review

Advantage Investment Management sold out of St Jude Medical (STJ) in Q4 2017, closing a stake of 100 shares — an estimated $6K sold.

Advantage Investment Management first reported a position in STJ in Q4 2014 and held it in 12 quarters. The position peaked at $6K in Q3 2017. 0 funds tracked by Wall St. Rank hold STJ as of Q4 2017.

  • Advantage Investment Management reported no remaining St Jude Medical position as of Q4 2017 after selling out during the quarter.
  • Advantage Investment Management sold 100 St Jude Medical shares in Q4 2017, an estimated $6K.
  • Advantage Investment Management first reported a position in St Jude Medical in Q4 2014 and held it in 12 quarters.
  • Advantage Investment Management's St Jude Medical position peaked at $6K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2017.

Based on Advantage Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.